FDA Recalls HydrOXYzine HCl Tablets Due to Unapproved Ingredient Source
American Health Packaging is recalling HydrOXYzine HCl 50 mg tablets because the active ingredient came from an unapproved source.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly identifies the recall as FDA Class II. According to the severity rubric, FDA Class II recalls are classified as Severe (Score 4).
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for HydrOXYzine HCl Tablets, USP 50 mg, 100 Tablet Blister, manufactured by KVK-TECH, INC. and distributed by American Health Packaging. The recall involves 8,570 blister packs distributed nationwide. The affected lots are 120757 (Exp. 02/14), 121104 (Exp. 03/14), 122055 (Exp. 05/14), 123038 (Exp. 07/14), and 125115 (Exp. 11/14).
The reason for the recall is a deviation from Good Manufacturing Practices (GMP). Specifically, the product contains an active pharmaceutical ingredient from an unapproved source. This classification is designated as Class II by the FDA.
Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be returned to the distributor or disposed of according to local regulations. Patients should consult their healthcare provider for alternative medication options if necessary.
The recalled product
- Product
- HydrOXYzine HCl Tablets, USP 50 mg, 100 Tablet Blister, Rx only Mfd by: KVK-TECH, INC. Newtown, PA 18940, NDC 68084-255-01
- Manufacturer
- American Health Packaging
- Category
- Drug — Prescription Medication
- Affected units
- 8,570
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot 120757
- Exp. 02/14
- Lot 121104
- Exp 03/14
- Lot 122055
- Exp 05/14
- Lot 123038
- Exp 07/14
- Lot 125115
- Exp 11/14
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by American Health Packaging under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · American Health Packaging
See all →- ModerateNitrofurantoin Capsules 100 mg recalled for failed dissolution specifications
FDA (Drugs) · 2022-05-25
- ModerateCyanocobalamin Injection Recalled Due to Subpotency and Assay Non-Compliance
FDA (Drugs) · 2022-05-04
- SevereOxycodone Hydrochloride Oral Solution Recall Due to Impurity Failure
FDA (Drugs) · 2022-03-16
- ModerateMetoprolol Succinate ER Tablets Recall for Failed Dissolution
FDA (Drugs) · 2022-02-02
- ModerateGlipiZIDE Extended-Release Tablets 2.5 mg Nationwide Recall
FDA (Drugs) · 2021-10-27
Same hazard · unapproved ingredient source
See all →- HighFDA recalls Ramipril 2.5 mg capsules for manufacturing control deviations
FDA (Drugs) · 2024-11-27
- ModerateFDA Recalls HydrOXYzine HCl Tablets Due to Unapproved Ingredient Source
FDA (Drugs) · 2014-04-09
- SevereKVK-Tech Recalls Hydroxyzine Hydrochloride Tablets Due to Unapproved Ingredient Source
FDA (Drugs) · 2014-01-29